Tuesday 20 February 2018
Contact US    |    Archive
Reuters
8 days ago

Drug copies ready to take next bite out of Roche s cancer sales

LONDON, Feb 13 (Reuters) - European oncologists will soon get their hands on cut-price copies of breast cancer drug Herceptin, turning the screws on maker Roche and giving another boost to a new breed of companies focused on so-called biosimilars.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Drug

 | 

copies

 | 

ready

 | 

take

 | 

next

 | 

bite

 | 

out

 | 

Roche

 | 

cancer

 | 

sales

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA